Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer

Ahlquist, 1997, Fecal occult blood testing for colorectal cancer. Can we afford to do this?, Gastroenterol. Clin. North Am., 26, 41, 10.1016/S0889-8553(05)70282-X Anderson, 2005, The sentinel within: exploiting the immune system for cancer biomarkers, J. Proteome Res., 4, 1123, 10.1021/pr0500814 Anderson, 2011, Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer, J. Proteome Res., 10, 85, 10.1021/pr100686b Babel, 2009, Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays, Mol. Cell. Proteomics, 8, 2382, 10.1074/mcp.M800596-MCP200 Belousov, 2008, Cancer-associated antigens and antigen arrays in serological diagnostics of malignant tumors, Biochemistry (Mosc), 73, 562, 10.1134/S000629790805009X Bentley, 2008, Accurate whole human genome sequencing using reversible terminator chemistry, Nature, 456, 53, 10.1038/nature07517 Berger, 2006, Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests, Clin. Colorectal Cancer, 5, 338, 10.3816/CCC.2006.n.003 Brown, 2012, Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer?, Cancer Epidemiol. Biomarkers Prev., 21, 337, 10.1158/1055-9965.EPI-11-0786 Casiano, 2006, Tumor-associated antigen arrays for the serological diagnosis of cancer, Mol. Cell. Proteomics, 5, 1745, 10.1074/mcp.R600010-MCP200 Chapman, 2008, Autoantibodies in lung cancer: possibilities for early detection and subsequent cure, Thorax, 63, 228, 10.1136/thx.2007.083592 Chee, 1996, Accessing genetic information with high-density DNA arrays, Science, 274, 610, 10.1126/science.274.5287.610 Chen, 2007, Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection, Int. J. Oncol., 30, 1137 Creeden, 2011, Serum tests for colorectal cancer screening, Mol. Diagn. Ther., 15, 129, 10.1007/BF03256403 Davies, 2005, Colorectal cancer screening: prospects for molecular stool analysis, Nat. Rev. Cancer, 5, 199, 10.1038/nrc1569 de Voer, 2008, Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides, Clin. Vaccine Immunol., 15, 1188, 10.1128/CVI.00478-07 Dettloff, 2008, Nucleic acid amplification of individual molecules in a microfluidic device, Anal. Chem., 80, 4208, 10.1021/ac800339w Doolittle, 2001, Detection of the mutated K-Ras biomarker in colorectal carcinoma, Exp. Mol. Pathol., 70, 289, 10.1006/exmp.2001.2364 Fodor, 1991, Light-directed, spatially addressable parallel chemical synthesis, Science, 251, 767, 10.1126/science.1990438 Fouda, 2006, Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens, Clin. Vaccine Immunol., 13, 1307, 10.1128/CVI.00183-06 Fulton, 1997, Advanced multiplexed analysis with the FlowMetrix system, Clin. Chem., 43, 1749, 10.1093/clinchem/43.9.1749 Gunderson, 2004, Decoding randomly ordered DNA arrays, Genome Res., 14, 870, 10.1101/gr.2255804 Hellemons, 2012, Growth-differentiation factor 15 predicts worsening of albuminuria in patients with type 2 diabetes, Diabetes Care, 35, 2340, 10.2337/dc12-0180 Howlader, 2012 Hudson, 2007, Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays, Proc. Natl. Acad. Sci. U. S. A., 104, 17494, 10.1073/pnas.0708572104 Keefe, 2001, One-step purification of recombinant proteins using a nanomolar-affinity streptavidin-binding peptide, the SBP-Tag, Protein Expr. Purif., 23, 440, 10.1006/prep.2001.1515 Koziol, 2003, Recursive partitioning as an approach to selection of immune markers for tumor diagnosis, Clin. Cancer Res., 9, 5120 Lin, 2009, Medium- to high-throughput SNP genotyping using VeraCode microbeads, Methods Mol. Biol., 496, 129, 10.1007/978-1-59745-553-4_10 Liu, 2009, Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer, Scand. J. Immunol., 69, 57, 10.1111/j.1365-3083.2008.02195.x Marchio, 2011, Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box, BMC Med., 9, 41, 10.1186/1741-7015-9-41 Margulies, 2005, Genome sequencing in microfabricated high-density picolitre reactors, Nature, 437, 376, 10.1038/nature03959 Nozoe, 2007, Clinicopathologic significance in serum presence of anti-p53 antibody in patients with colorectal carcinoma, Hepatogastroenterology, 54, 1422 Opalka, 2003, Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay, Clin. Diagn. Lab. Immunol., 10, 108, 10.1128/CDLI.10.1.108-115.2003 Plant, 1991, Immobilization of binding proteins on nonporous supports. Comparison of protein loading, activity, and stability, Appl. Biochem. Biotechnol., 30, 83, 10.1007/BF02922025 Reuschenbach, 2009, A systematic review of humoral immune responses against tumor antigens, Cancer Immunol. Immunother., 58, 1535, 10.1007/s00262-009-0733-4 Rex, 2009, American college of gastroenterology guidelines for colorectal cancer screening 2008, Am. J. Gastroenterol., 104, 739, 10.1038/ajg.2009.104 Saleh, 2004, p53 autoantibodies from patients with colorectal cancer recognize common epitopes in the N- or C-terminus of p53, Int. J. Oncol., 25, 1149 Schlottmann, 2006, A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheres, J. Immunol. Methods, 309, 75, 10.1016/j.jim.2005.11.019 Storr, 2006, Use of autoantibodies in breast cancer screening and diagnosis, Expert. Rev. Anticancer. Ther., 6, 1215, 10.1586/14737140.6.8.1215 Su, 2012, Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection, World J. Gastroenterol., 18, 2121, 10.3748/wjg.v18.i17.2121 Subramanian, 2004, Adherence with colorectal cancer screening guidelines: a review, Prev. Med., 38, 536, 10.1016/j.ypmed.2003.12.011 Toth, 2012, Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers, PloS One, 7, e46000, 10.1371/journal.pone.0046000 van't Veer, 2002, Gene expression profiling predicts clinical outcome of breast cancer, Nature, 415, 530, 10.1038/415530a Vijan, 2004, Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States, Aliment. Pharmacol. Ther., 20, 507, 10.1111/j.1365-2036.2004.01960.x Walhout, 2000, GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes, Methods Enzymol., 328, 575, 10.1016/S0076-6879(00)28419-X Wallin, 2011, Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer, Br. J. Cancer, 104, 1619, 10.1038/bjc.2011.112 Waterboer, 2006, Suppression of non-specific binding in serological Luminex assays, J. Immunol. Methods, 309, 200, 10.1016/j.jim.2005.11.008 Wollert, 2012, Growth differentiation factor 15 in heart failure: an update, Curr. Heart Fail. Rep., 9, 337, 10.1007/s11897-012-0113-9 Woolf, 2004, A smarter strategy? Reflections on fecal DNA screening for colorectal cancer, N. Engl. J. Med., 351, 2755, 10.1056/NEJMe048259 Xue, 2010, Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach, J. Proteome Res., 9, 545, 10.1021/pr9008817 Zhang, 2003, Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens, Cancer Epidemiol. Biomarkers Prev., 12, 136